10/18/2024 | BKHY | Moody’s views Sabra Health Care positively
|
5/10/2024 | BKBWHYIG | Sabra expects improvements to 5.55x debt ratio as portfolio recovers
|
9/21/2021 | HYIG | New Issue: Sabra Health prices $800 million 3.2% notes due 2031 at Treasuries plus 200 bps
|
9/21/2021 | BKHYIG | Moody's revises Sabra view to stable
|
9/27/2019 | HY | Market Commentary: Telesat, Calumet, Shutterfly price; AMN, Sabra new notes better; WeWork falls; PG&E, Sprint vary
|
9/26/2019 | HYIG | New Issue: Sabra Health sells $350 million 3.9% 10-year notes at 240 bps spread
|
5/21/2019 | HYIG | New Issue: Sabra Health prices $300 million 4.8% five-year notes at 260 bps over Treasuries
|
10/12/2018 | BKHYIG | Fitch revises Sabra Health view to negative
|
8/23/2017 | BKHYIGPF | Fitch lifts Sabra Health, withdraws Care Capital
|
8/21/2017 | BKHYIGPF | Moody’s ups Sabra, cuts Care Capital debt
|
8/17/2017 | BKHY | S&P affirms, withdraws Care Capital
|
8/17/2017 | BKHYIGPF | S&P ups Sabra, notes, preferreds
|
5/8/2017 | BKBWHYIG | Sabra, Care Capital merge; companies’ public bonds to survive merger
|
5/8/2017 | BKHYIGPF | Moody’s reviews Sabra, Care Capital
|
5/8/2017 | BKHYPF | Fitch reviews Sabra Health Care
|
5/8/2017 | BKHY | S&P puts Sabra Health Care on positive watch
|
10/19/2016 | BKHYPF | Moody’s ups Sabra Health to positive
|
6/16/2015 | BKHYPF | Fitch rates Sabra loan BB+/RR4
|
1/13/2015 | BKHYPF | S&P lifts Sabra notes, loans, preferreds
|
12/9/2014 | BKHYPF | Fitch: Sabra Health preferreds BB-; IDR, loans, notes BB+
|
10/3/2014 | HY | Market Commentary: Consolidated Energy two-parter, Halyard price; Zebra gain continues; funds lose $2.28 billion
|
10/1/2014 | HY | Market Commentary: Sabra Health REIT brings add-on deal; new Zebra bonds jump in heavy trading; McClatchy better
|
8/6/2014 | HY | Sabra Health Care REIT to take part in non-deal roadshow hosted by RBC
|
2/11/2014 | HYLM | Sabra Health Care redeems remaining 8 1/8% senior notes due 2018
|
1/9/2014 | HY | Market Commentary: Summit brings add-on; Fresenius restructures; T-Mobile rises; funds see $642 million inflows
|
1/8/2014 | HY | New Issue: Sabra sells upsized $350 million seven-year notes at par to yield 51/2%
|
1/8/2014 | HY | Market Commentary: Icahn's giant three-parter prices, along with Sabra Health; new Parker bonds rise, MDC busy
|
1/8/2014 | HY | Sabra Health Care to sell $300 million seven-year notes in Wednesday drive-by; guidance is 53/4%
|
1/8/2014 | HYLM | Sabra tenders, seeks consents for $211.3 million 8 1/8% notes due 2018
|
1/8/2014 | BKHY | S&P: Sabra Health notes BB-
|
1/8/2014 | BKHYPF | Moody's ups Sabra, rates notes Ba3
|
11/21/2013 | HY | Sabra Health Care REIT to participate in non-deal roadshow in Midwest
|
5/23/2013 | HYLM | Sabra Health subsidiaries to redeem portion of 8 1/8% notes on June 24
|
5/21/2013 | BKHYPF | Sabra Health Care REIT's latest senior notes offering boosts liquidity by $72 million, says CFO
|
5/21/2013 | HY | Market Commentary: Giant-sized Intelsat unit drive-by leads $4.8 billion session; Monday deals busily traded
|
5/20/2013 | HY | New Issue: Sabra Health Care prices $200 million 5 3/8% 10-year notes at par
|
5/20/2013 | HY | Market Commentary: B&G Foods, Sabra bring deals; Concho, Memorial Production do add-ons; calendar keeps building
|
5/20/2013 | HY | Market Commentary: B&G Foods, Sabra bring deals; Concho, Memorial Production do add-ons; calendar keeps building
|
5/20/2013 | HY | Sabra Health Care driving by with $200 million 10-year notes Monday
|
5/20/2013 | BKHYPF | Moody's rates Sabra debt B1, preferreds B3
|
5/20/2013 | HYLM | Sabra Health Care to redeem up to $113.75 million of 8 1/8% notes
|
5/20/2013 | BKHYPF | S&P assigns Sabra notes BB-
|
3/14/2013 | BKDDHYPF | S&P: Sabra preferreds CCC+
|
3/14/2013 | BKDDHYPF | Moody's: Sabra preferreds B3
|
7/23/2012 | HY | Market Commentary: Sabra brings small add-on; SPL, QR Energy ahead; Gen-On, GeoEye jump on merger deal news
|
7/23/2012 | HY | New Issue: Sabra Health Care sells upsized $100 million tap of 8 1/8% notes due 2018 at 106
|
7/23/2012 | HY | S&P: No change to Sabra Health
|
4/19/2012 | BKHY | Moody's ups Sabra Health
|
10/3/2011 | CVHYPF | Sabra Health Care files $500 million shelf for stock, debt, preferreds
|
11/19/2010 | HY | S&P rates Sabra, notes B
|
10/26/2010 | HY | Market Commentary: Oversubscribed Fortescue mega-deal prices, gains; new MGM struggles; market awaits Momentive
|
10/25/2010 | HY | Market Commentary: MGM sells $500 million eight-years, bonds rise; Dunkin' slates; Fortescue $2 billion awaits
|
10/22/2010 | HY | New Issue: Sabra Health Care prices $225 million 8 1/8% eight-year notes at par
|
10/22/2010 | HY | Market Commentary: Omnova, Sabra, Prestige price, gain in trading; Momentive, Hexion bonds busy on new-deal news
|
10/21/2010 | HY | Market Commentary: United Rentals, American Achievement price, rise; Omnova, Sabra await; funds up $347 million
|
10/21/2010 | HY | Sabra Healthcare talks $225 million eight-year notes at 81/4% area yield
|
10/15/2010 | HY | Market Commentary: TXU, Air Medical, Tutor Perini deals price, Air Medical sizzles but TXU fizzles; Sabra slates
|
10/15/2010 | HY | Sabra Healthcare begins roadshow Monday for bonds to back spinoff
|
10/15/2010 | HY | Moody's rates Sabra notes B2
|
9/27/2010 | BKHY | Sun Healthcare, Sabra expect $385 million loans, $225 million notes
|
9/27/2010 | BKHY | Sabra Healthcare to get $100 million revolver, $225 million notes
|
8/25/2010 | HY | Sun Healthcare mulls bond option for $197.5 million of new Sabra debt to fund spinoff
|